Prostatis Group’s Vanguard Total International Stock ETF VXUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,996
Closed -$422K 158
2024
Q2
$422K Buy
6,996
+21
+0.3% +$1.27K 0.15% 103
2024
Q1
$421K Buy
+6,975
New +$406K 0.16% 100
2023
Q3
Sell
-7,804
Closed -$438K 248
2023
Q2
$438K Sell
7,804
-49
-0.6% -$2.74K 0.2% 75
2023
Q1
$442K Sell
7,853
-126,074
-94% -$6.89M 0.23% 71
2022
Q4
$6.93M Buy
+133,927
New +$6.7M 4.23% 4
2021
Q2
Sell
-8,113
Closed -$509K 108
2021
Q1
$509K Sell
8,113
-86,391
-91% -$5.42M 0.4% 59
2020
Q4
$5.69M Buy
+94,504
New +$5.32M 4.76% 5

Other funds holding VXUS

Prostatis Group's VXUS Position: Q3 2024 in Review

Prostatis Group sold out of Vanguard Total International Stock ETF (VXUS) in Q3 2024, closing a stake of 6,996 shares — an estimated $422K sold.

Prostatis Group first reported a position in VXUS in Q4 2020 and held it in 7 quarters. The position peaked at $6.93M in Q4 2022. 1,181 funds tracked by Wall St. Rank hold VXUS as of Q3 2024.

  • Prostatis Group reported no remaining Vanguard Total International Stock ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 6,996 Vanguard Total International Stock ETF shares in Q3 2024, an estimated $422K.
  • Prostatis Group first reported a position in Vanguard Total International Stock ETF in Q4 2020 and held it in 7 quarters.
  • Prostatis Group's Vanguard Total International Stock ETF position peaked at $6.93M in Q4 2022.
  • 1,181 funds tracked by Wall St. Rank held Vanguard Total International Stock ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.